Your browser doesn't support javascript.
loading
A phase I trial of intraperitoneal GEN-1, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer, administered with pegylated liposomal doxorubicin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancers: An NRG Oncology/Gynecologic Oncology Group study.
Thaker, Premal H; Brady, William E; Lankes, Heather A; Odunsi, Kunle; Bradley, William H; Moore, Kathleen N; Muller, Carolyn Y; Anwer, Khursheed; Schilder, Russell J; Alvarez, Ronald D; Fracasso, Paula M.
Afiliação
  • Thaker PH; Division of Gynecologic Oncology, Washington University School of Medicine and Siteman Cancer Center, St. Louis, MO, USA. Electronic address: thakerp@wudosis.wustl.edu.
  • Brady WE; NRG Oncology Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY, USA. Electronic address: bbrady@gogstats.org.
  • Lankes HA; NRG Oncology Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY, USA. Electronic address: LankesH@NRGOncology.org.
  • Odunsi K; Department of Gynecology, Roswell Park Cancer Institute, Buffalo, NY, USA. Electronic address: Kunle.Odunsi@RoswellPark.org.
  • Bradley WH; Division of Gynecologic Oncology, Medical College of Wisconsin, Milwaukee, WI, USA. Electronic address: wbradley@mcw.edu.
  • Moore KN; Division of Gynecologic Oncology, University of Oklahoma and Stephenson Cancer Center, Oklahoma City, OK, USA. Electronic address: kathleen-moore@ouhsc.edu.
  • Muller CY; University of New Mexico, Albuquerque, NM, USA. Electronic address: cmuller@salud.unm.edu.
  • Anwer K; Celsion Corporation, Lawrenceville, NJ, USA. Electronic address: KAnwer@celsion.com.
  • Schilder RJ; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, USA. Electronic address: russell.schilder@jefferson.edu.
  • Alvarez RD; Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: ralvarez@uabmc.edu.
  • Fracasso PM; Department of Medicine and the UVA Cancer Center, University of Virginia, Charlottesville, VA, USA. Electronic address: fracasso@virginia.edu.
Gynecol Oncol ; 147(2): 283-290, 2017 11.
Article em En | MEDLINE | ID: mdl-28802766
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Peritoneais / Terapia Genética / Doxorrubicina / Neoplasias Epiteliais e Glandulares / Interleucina-12 / Neoplasias das Tubas Uterinas Limite: Aged / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Peritoneais / Terapia Genética / Doxorrubicina / Neoplasias Epiteliais e Glandulares / Interleucina-12 / Neoplasias das Tubas Uterinas Limite: Aged / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Ano de publicação: 2017 Tipo de documento: Article